Sabzevari Helen
CIK 0001724195
President and CEODirector
Filings
28
Latest Jun 1, 2026
Issuers covered
2
Showing
28 of 28
Page 1
Track record
9 of 10 open-market trades scored (90% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 67% | +8.0% | +10.6% | +41.5% | -47.7% |
| 90 days | 9 | 67% | +7.5% | +26.2% | +36.4% | -71.9% |
| 180 days | 9 | 67% | +16.1% | +13.0% | +59.3% | -24.3% |
| 365 days | 9 | 78% | +26.9% | +30.5% | +62.8% | -18.0% |
Issuers
Companies where Sabzevari Helen has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PGEN | Precigen, Inc. | 25 | Jun 1, 2026 |
| KNTE | Kinnate Biopharma Inc. | 3 | Apr 5, 2024 |
All filings
28 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|